OXBOF Financials: Oxford BioDynamics Plc AI Analysis

Home

Stock

OXBOF

Financials

OXBOF Financial

Oxford BioDynamics Plc

At close: Mar 25, 16:00:00 GMT-4

Post-market: Mar 25, 20:20:19 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.002

Open

$0.0035

Day's Range

$0.002 - $0.0035

52 week range

$0.0014 - $0.0133

Volume

110.0K

Avg.Volume

5.0K

Dividend yield

EPS (TTM)

-0.01

Market Cap

$8.5M

What is OXFORD BIODYNAMICS PLC?

Oxford BioDynamics Plc is a biotechnology company, which engages in the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The firm is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

OXBOF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
Revenue	1	1	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	--
Gross Profit	0	0	0	0	0	--
Selling, General & Admin	9	9	10	9	7	5
Research & Development	0	0	0	0	0	0
Operating Expenses	11	11	12	10	8	7
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-11	-11	-11	-11	-7	-7
Income Tax Expense	0	0	0	0	0	0
Net Income	-11	-11	-11	-10	-6	-6
Net Income Growth	0%	0%	10%	67%	0%	50%
Shares Outstanding (Diluted)	1,923.37	1,387.07	255.72	147.48	99.7	92.55
Shares Change (YoY)	522%	442%	73%	48%	8%	0%
EPS (Diluted)	0	0	-0.04	-0.07	-0.06	-0.07
EPS Growth	-79%	-82%	-38%	9%	-7%	54%
Free Cash Flow	-7	-7	-10	-9	-6	-9
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	0%	0%	0%	--
Operating Margin	-1,000%	-1,000%	0%	0%	0%	0%
Profit Margin	-1,100%	-1,100%	0%	0%	0%	0%
Free Cash Flow Margin	-700%	-700%	0%	0%	0%	0%
EBITDA	-9	-9	-10	-9	-7	-6
EBITDA Margin	-900%	-900%	0%	0%	0%	0%
D&A For EBITDA	1	1	1	1	1	1
EBIT	-10	-10	-11	-10	-8	-7
EBIT Margin	-1,000%	-1,000%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Oxford BioDynamics Plc's key financial statements?



According to the latest financial statement (Form-10K), Oxford BioDynamics Plc has a total asset of $8, Net loss of $-11

What are the key financial ratios for OXBOF?



Oxford BioDynamics Plc's Current ratio is 1.33, has a Net margin is -1,100, sales per share of $0.

How is Oxford BioDynamics Plc's revenue broken down by segment or geography?



Oxford BioDynamics Plc largest revenue segment is Proprietary Products, at a revenue of 408,000 in the most earnings release.For geography, United States is the primary market for Oxford BioDynamics Plc, at a revenue of 459,000.

Is Oxford BioDynamics Plc profitable?



no, according to the latest financial statements, Oxford BioDynamics Plc has a net loss of $-11

Does Oxford BioDynamics Plc have any liabilities?



yes, Oxford BioDynamics Plc has liability of 6

How many outstanding shares for Oxford BioDynamics Plc?



Oxford BioDynamics Plc has a total outstanding shares of 1,957.57

Oxford BioDynamics Plc (OXBOF) Financial

OXBOF Stock Price Chart